Sinovac Biotech annual operating margin
2009
2010
2011
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sinovac Biotech Operating Margin Growth & History (SVA)
Sinovac Biotech's operating margin was −126.97% for fiscal 2025.
View full Sinovac Biotech company overviewSinovac Biotech annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −126.97% | +12.92 pp |
| 2024 | 2024-12-31 | −139.89% | +11.96 pp |
| 2023 | 2023-12-31 | −151.86% | −117.31 pp |
| 2022 | 2022-12-31 | −34.54% | −125.52 pp |
| 2021 | 2021-12-31 | 90.98% | +48.75 pp |
| 2020 | 2020-12-31 | 42.23% | +14.37 pp |
| 2019 | 2019-12-31 | 27.86% | +8.13 pp |
| 2018 | 2018-12-31 | 19.73% | −6.32 pp |
| 2017 | 2017-12-31 | 26.05% | +25.35 pp |
| 2016 | 2016-12-31 | 0.70% | −5.24 pp |
| 2011 | 2011-12-31 | 5.94% | +45.92 pp |
| 2010 | 2010-12-31 | −39.99% | −90.05 pp |
| 2009 | 2009-12-31 | 50.06% | — |
Sinovac Biotech quarterly operating margin
No reported data
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|
Sinovac Biotech operating margin trends
Over the last five reported fiscal years, Sinovac Biotech's operating margin decreased from 42.23% to −126.97%, a change of −169.20 percentage points.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sinovac Biotech filings at SEC.gov ↗